![]() |
|
|
Zentrum für Physiologie und Pathophysiologie, Abt. Vegetative Physiologie und Pathophysiologie, (A.B., C.E., D.E., G.B., Y.H.); Zentrum für Physiologie und Pathophysiologie, Abt. Neuro- und Sinnesphysiologie, (E.G.P.); and Zentrum Pathologie, Universität Göttingen, Göttingen, Germany (L.F.)
The human organic anion transporter 1 (hOAT1) facilitates the basolateral entry of organic anions such as endogenous metabolites, xenobiotics, and drugs into the proximal tubule cells. In the present study we investigated the general occurrence of hOAT1 isoforms in the kidneys and performed functional characterizations. Kidney specimens of 10 patients were analyzed by reverse transcription-polymerase chain reaction. We detected hOAT1-2 as the main transcript in almost all patients, and weak transcripts of hOAT1-1, hOAT1-3, and hOAT1-4 in many of them. An evaluation of the renal distribution showed all four mRNAs mostly restricted to the cortex. Western blot analysis of membrane fractions from two kidney specimens yielded two bands corresponding to the observed mRNA expression, suggesting hOAT1-3 and hOAT1-4 to be expressed on the protein level in vivo. This observation is further supported by immunofluorescence analyses of all four cloned hOAT1 isoforms transiently transfected in COS 7 cells. Functional characterizations did not show any transport activity of hOAT1-3 and hOAT1-4 for the tested substrates. Cotransfection studies of each of them with hOAT1-1 did not alter fluorescein uptake indicating no regulatory impact of these isoforms. Further functional comparisons of hOAT1-1 and hOAT1-2 in fluorescein uptake studies exhibited almost identical affinities for fluorescein with Michaelis constants of 11.6 ± 3.7 µM (hOAT1-1) and 11.9 ± 6.4 µM (hOAT1-2), and similar sensitivities to inhibition by p-aminohippurate [IC50: 16 µM (hOAT1-1), 10 µM (hOAT1-2)], urate [IC50: 440 µM (hOAT1-1), 385 µM (hOAT1-2)], and furosemide (IC50: 14 µM (hOAT1-1), 20 µM (hOAT1-2)], implying functional equivalence.
This article has been cited by other articles:
![]() |
C. D. Cropp, T. Komori, J. E. Shima, T. J. Urban, S. W. Yee, S. S. More, and K. M. Giacomini Organic Anion Transporter 2 (SLC22A7) Is a Facilitative Transporter of cGMP Mol. Pharmacol., April 1, 2008; 73(4): 1151 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kwon, S.-M. Hong, and K. Blouch Alteration in Renal Organic Anion Transporter 1 After Ischemia/Reperfusion in Cadaveric Renal Allografts J. Histochem. Cytochem., June 1, 2007; 55(6): 575 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Rizwan, W. Krick, and G. Burckhardt The Chloride Dependence of the Human Organic Anion Transporter 1 (hOAT1) Is Blunted by Mutation of a Single Amino Acid J. Biol. Chem., May 4, 2007; 282(18): 13402 - 13409. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Henderson and M. A. Smith Perfluorooctanoic Acid and Perfluorononanoic Acid in Fetal and Neonatal Mice Following In Utero Exposure to 8-2 Fluorotelomer Alcohol Toxicol. Sci., February 1, 2007; 95(2): 452 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Eraly, V. Vallon, D. A. Vaughn, J. A. Gangoiti, K. Richter, M. Nagle, J. C. Monte, T. Rieg, D. M. Truong, J. M. Long, et al. Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice J. Biol. Chem., February 24, 2006; 281(8): 5072 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Q. P. Yin, B. Tomlinson, and M. S. S. Chow Variability in Renal Clearance of Substrates for Renal Transporters in Chinese Subjects J. Clin. Pharmacol., February 1, 2006; 46(2): 157 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bahn, M. Ljubojevic, H. Lorenz, C. Schultz, E. Ghebremedhin, B. Ugele, I. Sabolic, G. Burckhardt, and Y. Hagos Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1075 - C1084. [Abstract] [Full Text] [PDF] |
||||